Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1995 Apr;39(4):797–805. doi: 10.1128/aac.39.4.797

Insights into erythromycin action from studies of its activity as inducer of resistance.

B Weisblum 1
PMCID: PMC162632  PMID: 7785974

Full Text

The Full Text of this article is available as a PDF (236.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen N. E. Macrolide resistance in Staphylococcus aureus: inducers of macrolide resistance. Antimicrob Agents Chemother. 1977 Apr;11(4):669–674. doi: 10.1128/aac.11.4.669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Allen N. E. Macrolide resistance in Staphylococcus aureus: induction of macrolide-resistant protein synthesis. Antimicrob Agents Chemother. 1977 Apr;11(4):661–668. doi: 10.1128/aac.11.4.661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Andersson S., Kurland C. G. Elongating ribosomes in vivo are refractory to erythromycin. Biochimie. 1987 Aug;69(8):901–904. doi: 10.1016/0300-9084(87)90218-5. [DOI] [PubMed] [Google Scholar]
  4. Bechhofer D. H., Zen K. H. Mechanism of erythromycin-induced ermC mRNA stability in Bacillus subtilis. J Bacteriol. 1989 Nov;171(11):5803–5811. doi: 10.1128/jb.171.11.5803-5811.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bourse R., Monnier J. Effet de l'érythromycine sur la croissae de Staph. aureus "resistant dissocié" en bactériostase par un autre macrolide ou un antibiotique apparenté. Ann Inst Pasteur (Paris) 1967 Jul;113(1):67–79. [PubMed] [Google Scholar]
  6. Breidt F., Dubnau D. Identification of cis-acting sequences required for translational autoregulation of the ermC methylase. J Bacteriol. 1990 Jul;172(7):3661–3668. doi: 10.1128/jb.172.7.3661-3668.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. CHABBERT Y. Antagonisme in vitro entre l'érythromycine et la spiramycine. Ann Inst Pasteur (Paris) 1956 Jun;90(6):787–790. [PubMed] [Google Scholar]
  8. Contreras A., Vázquez D. Cooperative and antagonistic interactions of peptidyl-tRNA and antibiotics with bacterial ribosomes. Eur J Biochem. 1977 Apr 15;74(3):539–547. doi: 10.1111/j.1432-1033.1977.tb11422.x. [DOI] [PubMed] [Google Scholar]
  9. Cundliffe E., McQuillen K. Bacterial protein synthesis: the effects of antibiotics. J Mol Biol. 1967 Nov 28;30(1):137–146. doi: 10.1016/0022-2836(67)90249-5. [DOI] [PubMed] [Google Scholar]
  10. Denoya C. D., Bechhofer D. H., Dubnau D. Translational autoregulation of ermC 23S rRNA methyltransferase expression in Bacillus subtilis. J Bacteriol. 1986 Dec;168(3):1133–1141. doi: 10.1128/jb.168.3.1133-1141.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. DiMari J. F., Bechhofer D. H. Initiation of mRNA decay in Bacillus subtilis. Mol Microbiol. 1993 Mar;7(5):705–717. doi: 10.1111/j.1365-2958.1993.tb01161.x. [DOI] [PubMed] [Google Scholar]
  12. Dontsova O., Tishkov V., Dokudovskaya S., Bogdanov A., Döring T., Rinke-Appel J., Thamm S., Greuer B., Brimacombe R. Stem-loop IV of 5S rRNA lies close to the peptidyltransferase center. Proc Natl Acad Sci U S A. 1994 May 10;91(10):4125–4129. doi: 10.1073/pnas.91.10.4125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Dubnau D. Induction of ermC requires translation of the leader peptide. EMBO J. 1985 Feb;4(2):533–537. doi: 10.1002/j.1460-2075.1985.tb03661.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Döring T., Greuer B., Brimacombe R. The three-dimensional folding of ribosomal RNA; localization of a series of intra-RNA cross-links in 23S RNA induced by treatment of Escherichia coli 50S ribosomal subunits with bis-(2-chloroethyl)-methylamine. Nucleic Acids Res. 1991 Jul 11;19(13):3517–3524. doi: 10.1093/nar/19.13.3517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Goldman R. C., Kadam S. K. Binding of novel macrolide structures to macrolides-lincosamides-streptogramin B-resistant ribosomes inhibits protein synthesis and bacterial growth. Antimicrob Agents Chemother. 1989 Jul;33(7):1058–1066. doi: 10.1128/aac.33.7.1058. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gryczan T. J., Grandi G., Hahn J., Grandi R., Dubnau D. Conformational alteration of mRNA structure and the posttranscriptional regulation of erythromycin-induced drug resistance. Nucleic Acids Res. 1980 Dec 20;8(24):6081–6097. doi: 10.1093/nar/8.24.6081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Gryczan T. J., Israeli-Reches M., Dubnau D. Induction of macrolide-lincosamide-streptogramin B resistance requires ribosomes able to bind inducer. Mol Gen Genet. 1984;194(3):357–361. doi: 10.1007/BF00425544. [DOI] [PubMed] [Google Scholar]
  18. Gryczan T., Israeli-Reches M., Del Bue M., Dubnau D. DNA sequence and regulation of ermD, a macrolide-lincosamide-streptogramin B resistance element from Bacillus licheniformis. Mol Gen Genet. 1984;194(3):349–356. doi: 10.1007/BF00425543. [DOI] [PubMed] [Google Scholar]
  19. Gu Z., Harrod R., Rogers E. J., Lovett P. S. Anti-peptidyl transferase leader peptides of attenuation-regulated chloramphenicol-resistance genes. Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5612–5616. doi: 10.1073/pnas.91.12.5612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Gu Z., Harrod R., Rogers E. J., Lovett P. S. Properties of a pentapeptide inhibitor of peptidyltransferase that is essential for cat gene regulation by translation attenuation. J Bacteriol. 1994 Oct;176(20):6238–6244. doi: 10.1128/jb.176.20.6238-6244.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Gu Z., Rogers E. J., Lovett P. S. Peptidyl transferase inhibition by the nascent leader peptide of an inducible cat gene. J Bacteriol. 1993 Sep;175(17):5309–5313. doi: 10.1128/jb.175.17.5309-5313.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Hahn J., Grandi G., Gryczan T. J., Dubnau D. Translational attenuation of ermC: a deletion analysis. Mol Gen Genet. 1982;186(2):204–216. doi: 10.1007/BF00331851. [DOI] [PubMed] [Google Scholar]
  23. Horinouchi S., Byeon W. H., Weisblum B. A complex attenuator regulates inducible resistance to macrolides, lincosamides, and streptogramin type B antibiotics in Streptococcus sanguis. J Bacteriol. 1983 Jun;154(3):1252–1262. doi: 10.1128/jb.154.3.1252-1262.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Horinouchi S., Weisblum B. Posttranscriptional modification of mRNA conformation: mechanism that regulates erythromycin-induced resistance. Proc Natl Acad Sci U S A. 1980 Dec;77(12):7079–7083. doi: 10.1073/pnas.77.12.7079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Horinouchi S., Weisblum B. The control region for erythromycin resistance: free energy changes related to induction and mutation to constitutive expression. Mol Gen Genet. 1981;182(2):341–348. doi: 10.1007/BF00269681. [DOI] [PubMed] [Google Scholar]
  26. Kadam S. K. Induction of ermC methylase in the absence of macrolide antibiotics and by pseudomonic acid A. J Bacteriol. 1989 Aug;171(8):4518–4520. doi: 10.1128/jb.171.8.4518-4520.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Kim H. S., Choi E. C., Kim B. K. A macrolide-lincosamide-streptogramin B resistance determinant from Bacillus anthracis 590: cloning and expression of ermJ. J Gen Microbiol. 1993 Mar;139(3):601–607. doi: 10.1099/00221287-139-3-601. [DOI] [PubMed] [Google Scholar]
  28. Kolter R., Yanofsky C. Attenuation in amino acid biosynthetic operons. Annu Rev Genet. 1982;16:113–134. doi: 10.1146/annurev.ge.16.120182.000553. [DOI] [PubMed] [Google Scholar]
  29. Kwak J. H., Choi E. C., Weisblum B. Transcriptional attenuation control of ermK, a macrolide-lincosamide-streptogramin B resistance determinant from Bacillus licheniformis. J Bacteriol. 1991 Aug;173(15):4725–4735. doi: 10.1128/jb.173.15.4725-4735.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Lai C. J., Dahlberg J. E., Weisblum B. Structure of an inducibly methylatable nucleotide sequence in 23S ribosomal ribonucleic acid from erythromycin-resistant Staphylococcus aureus. Biochemistry. 1973 Jan 30;12(3):457–460. doi: 10.1021/bi00727a015. [DOI] [PubMed] [Google Scholar]
  31. Lai C. J., Weisblum B. Altered methylation of ribosomal RNA in an erythromycin-resistant strain of Staphylococcus aureus. Proc Natl Acad Sci U S A. 1971 Apr;68(4):856–860. doi: 10.1073/pnas.68.4.856. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Lampson B. C., Parisi J. T. Naturally occurring Staphylococcus epidermidis plasmid expressing constitutive macrolide-lincosamide-streptogramin B resistance contains a deleted attenuator. J Bacteriol. 1986 May;166(2):479–483. doi: 10.1128/jb.166.2.479-483.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Lovett P. S. Translational attenuation as the regulator of inducible cat genes. J Bacteriol. 1990 Jan;172(1):1–6. doi: 10.1128/jb.172.1.1-6.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Mayford M., Weisblum B. Conformational alterations in the ermC transcript in vivo during induction. EMBO J. 1989 Dec 20;8(13):4307–4314. doi: 10.1002/j.1460-2075.1989.tb08617.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Mayford M., Weisblum B. The ermC leader peptide: amino acid alterations leading to differential efficiency of induction by macrolide-lincosamide-streptogramin B antibiotics. J Bacteriol. 1990 Jul;172(7):3772–3779. doi: 10.1128/jb.172.7.3772-3779.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Mayford M., Weisblum B. ermC leader peptide. Amino acid sequence critical for induction by translational attenuation. J Mol Biol. 1989 Mar 5;206(1):69–79. doi: 10.1016/0022-2836(89)90524-x. [DOI] [PubMed] [Google Scholar]
  37. Menninger J. R. Functional consequences of binding macrolides to ribosomes. J Antimicrob Chemother. 1985 Jul;16 (Suppl A):23–34. doi: 10.1093/jac/16.suppl_a.23. [DOI] [PubMed] [Google Scholar]
  38. Menninger J. R., Otto D. P. Erythromycin, carbomycin, and spiramycin inhibit protein synthesis by stimulating the dissociation of peptidyl-tRNA from ribosomes. Antimicrob Agents Chemother. 1982 May;21(5):811–818. doi: 10.1128/aac.21.5.811. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Narayanan C. S., Dubnau D. Demonstration of erythromycin-dependent stalling of ribosomes on the ermC leader transcript. J Biol Chem. 1987 Feb 5;262(4):1766–1771. [PubMed] [Google Scholar]
  40. Odom O. W., Picking W. D., Tsalkova T., Hardesty B. The synthesis of polyphenylalanine on ribosomes to which erythromycin is bound. Eur J Biochem. 1991 Jun 15;198(3):713–722. doi: 10.1111/j.1432-1033.1991.tb16071.x. [DOI] [PubMed] [Google Scholar]
  41. PATTEE P. A., BALDWIN J. N. Transduction of resistance to some macrolide antibiotics in Staphylococcus aureus. J Bacteriol. 1962 Nov;84:1049–1055. doi: 10.1128/jb.84.5.1049-1055.1962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Pestka S., Vince R., LeMahieu R., Weiss F., Fern L., Unowsky J. Induction of erythromycin resistance in Staphyloccus aureus by erythromycin derivatives. Antimicrob Agents Chemother. 1976 Jan;9(1):128–130. doi: 10.1128/aac.9.1.128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Ryabova L. A., Selivanova O. M., Baranov V. I., Vasiliev V. D., Spirin A. S. Does the channel for nascent peptide exist inside the ribosome? Immune electron microscopy study. FEBS Lett. 1988 Jan 4;226(2):255–260. doi: 10.1016/0014-5793(88)81434-0. [DOI] [PubMed] [Google Scholar]
  44. Sandler P., Weisblum B. Erythromycin-induced ribosome stall in the ermA leader: a barricade to 5'-to-3' nucleolytic cleavage of the ermA transcript. J Bacteriol. 1989 Dec;171(12):6680–6688. doi: 10.1128/jb.171.12.6680-6688.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Shields D. C., Sharp P. M. Synonymous codon usage in Bacillus subtilis reflects both translational selection and mutational biases. Nucleic Acids Res. 1987 Oct 12;15(19):8023–8040. doi: 10.1093/nar/15.19.8023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Shivakumar A. G., Hahn J., Grandi G., Kozlov Y., Dubnau D. Posttranscriptional regulation of an erythromycin resistance protein specified by plasmic pE194. Proc Natl Acad Sci U S A. 1980 Jul;77(7):3903–3907. doi: 10.1073/pnas.77.7.3903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Skinner R., Cundliffe E., Schmidt F. J. Site of action of a ribosomal RNA methylase responsible for resistance to erythromycin and other antibiotics. J Biol Chem. 1983 Oct 25;258(20):12702–12706. [PubMed] [Google Scholar]
  48. Stade K., Riens S., Bochkariov D., Brimacombe R. Contacts between the growing peptide chain and the 23S RNA in the 50S ribosomal subunit. Nucleic Acids Res. 1994 Apr 25;22(8):1394–1399. doi: 10.1093/nar/22.8.1394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Tai P. C., Wallace B. J., Davis B. D. Selective action of erythromycin on initiating ribosomes. Biochemistry. 1974 Oct 22;13(22):4653–4659. doi: 10.1021/bi00719a029. [DOI] [PubMed] [Google Scholar]
  50. Vazquez D. Antibiotics affecting chloramphenicol uptake by bacteria. Their effect on amino acid incorporation in a cell-free system. Biochim Biophys Acta. 1966 Feb 21;114(2):289–295. doi: 10.1016/0005-2787(66)90310-8. [DOI] [PubMed] [Google Scholar]
  51. Vazquez D. Binding of chloramphenicol to ribosomes. The effect of a number of antibiotics. Biochim Biophys Acta. 1966 Feb 21;114(2):277–288. doi: 10.1016/0005-2787(66)90309-1. [DOI] [PubMed] [Google Scholar]
  52. Vazquez D., Monro R. E. Effects of some inhibitors of protein synthesis on the binding of aminoacyl tRNA to ribosomal subunits. Biochim Biophys Acta. 1967 Jun 20;142(1):155–173. doi: 10.1016/0005-2787(67)90524-2. [DOI] [PubMed] [Google Scholar]
  53. Vester B., Garrett R. A. A plasmid-coded and site-directed mutation in Escherichia coli 23S RNA that confers resistance to erythromycin: implications for the mechanism of action of erythromycin. Biochimie. 1987 Aug;69(8):891–900. doi: 10.1016/0300-9084(87)90217-3. [DOI] [PubMed] [Google Scholar]
  54. Vázquez D. Inhibitors of protein biosynthesis. Mol Biol Biochem Biophys. 1979;30:i-x, 1-312. doi: 10.1007/978-3-642-81309-2. [DOI] [PubMed] [Google Scholar]
  55. WEAVER J. R., PATTEE P. A. INDUCIBLE RESISTANCE TO ERYTHROMYCIN IN STAPHYLOCOCCUS AUREUS. J Bacteriol. 1964 Sep;88:574–580. doi: 10.1128/jb.88.3.574-580.1964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Watanakunakorn C. Clindamycin therapy of Staphylococcus aureus endocarditis. Clinical relapse and development of resistance to clindamycin, lincomycin and erythromycin. Am J Med. 1976 Mar;60(3):419–425. doi: 10.1016/0002-9343(76)90758-0. [DOI] [PubMed] [Google Scholar]
  57. Weisblum B., Demohn V. Erythromycin-inducible resistance in Staphylococcus aureus: survey of antibiotic classes involved. J Bacteriol. 1969 May;98(2):447–452. doi: 10.1128/jb.98.2.447-452.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Weisblum B. Erythromycin resistance by ribosome modification. Antimicrob Agents Chemother. 1995 Mar;39(3):577–585. doi: 10.1128/AAC.39.3.577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Weisblum B., Siddhikol C., Lai C. J., Demohn V. Erythromycin-inducible resistance in Staphylococcus aureus: requirements for induction. J Bacteriol. 1971 Jun;106(3):835–847. doi: 10.1128/jb.106.3.835-847.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Yonath A., Leonard K. R., Wittmann H. G. A tunnel in the large ribosomal subunit revealed by three-dimensional image reconstruction. Science. 1987 May 15;236(4803):813–816. doi: 10.1126/science.3576200. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES